Alnylam Pharmaceuticals | ALNY - Capitalización De Mercado

Precio De Mercado
301.30
Cambio Diario
-0.81 -0.27%
Mensual
-4.68%
Anual
14.46%
Q2 Expectativa
299.00




Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.53B 57M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 263.08B 17.01B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Sanofi EUR 117.34B 2.45B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12